Stina Söderlund

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

Johan Richter, Joëlle Guilhot, Franz Gruber et al. · The Lancet Oncology · 2018 · 587 citations · Full text

Hematological Malignancy, Medicine, Chronic Myeloid Leukaemia +10

Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia

Lisa Christiansson, Stina Söderlund, Emma Svensson et al. · PLoS ONE · 2013 · 123 citations · Full text

Studies on metal content in the brown seaweed, Fucus vesiculosus, from the Archipelago of Stockholm

Anna Forsberg, Stina Söderlund, Adrian Frank et al. · Environmental Pollution · 1988 · 99 citations

Environmental Chemistry, Metal Content, Engineering +10

The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses

Lisa Christiansson, Stina Söderlund, Sara M. Mangsbo et al. · Molecular Cancer Therapeutics · 2015 · 65 citations

Hematological Malignancy, Tki Initiation, Chronic Myeloid Leukemia +14

Intestinal flora in very low‐birth weight infants

Markus V. Björkström, Lina Hall, Stina Söderlund et al. · Acta Paediatrica · 2009 · 64 citations